Biosynthesis of antibacterial zinc oxide nanoparticles from endophytic Streptomyces werraensis Authors: Prachi Patel, Mohammed Al-zharani, Mohammed Mubarak, Fahd A. Nasr, Nadiah S. Alzahrani, Sanjay Ingle, Ching Siang Tan, Jayanthi Barasarathi, Riyaz Sayyed, Anand Dave Published: 2026 ABSTRACT The rising prevalence of multidrug-resistant (MDR) pathogens necessitates the development of sustainable, biocompatible antimicrobial agents. Green synthesis of metal oxide nanoparticles using endophytic microorganisms offers an eco-friendly and bioactive alternative to conventional physical and chemical methods. In this study, zinc oxide nanoparticles (ZnO NPs) were biosynthesized using the cell-free supernatant of Streptomyces werraensis, a novel endophytic actinobacterium isolated from the medicinal plant Passiflora caerulea L. The formation of ZnO NPs was monitored via UV–visible spectroscopy and Fourier Transform Infrared (FTIR) spectroscopy. Morphological and structural characterizations were performed using Transmission Electron Microscopy (TEM), Selected Area Electron Diffraction (SAED), and Dynamic Light Scattering (DLS). The biological potential of ZnO NPs for human health was evaluated through antibacterial assays against a panel of human pathogens and antioxidant assays (DPPH and ABTS). UV–Vis spectra confirmed ZnONP formation with a characteristic band-gap absorption, while FTIR identified proteinaceous and phenolic capping agents. TEM and SAED revealed highly crystalline, predominantly spherical nanoparticles with an average diameter of 136 nm and a wurtzite crystal structure. The biosynthesized ZnO NPs exhibited potent, concentration-dependent antibacterial activity, particularly against Gram-negative strains; Salmonella paratyphi A and Proteus vulgaris showed maximum inhibition zones of 19.0 ± 0.64 mm and 16.4 ± 0.68 mm, respectively, which are comparable to those of commercial ampicillin. Antioxidant assays demonstrated significant radical-scavenging potential, with an IC50 of 22.15 ± 1.2 µg/mL in the ABTS assay, approaching that of ascorbic acid. The findings of the present study demonstrate that S. werraensis-mediated ZnO NPs serve as effective “nanogenerators” of oxidative stress, offering a dual-action therapeutic approach. These results highlight the potential of endophytic actinobacteria as sustainable bio-factories for producing functional nanoparticles with promising antimicrobial potential for treating MDR infections.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-026-54975-2. Introduction Zinc oxide nanoparticles (ZnO NPs) are significant in nanoscience due to their unique physicochemical properties, including a wide band gap, high exciton binding energy, and notable catalytic activity—enabling applications in electronics, sensors, photocatalysis, and biomedicine1. However, conventional chemical and physical synthesis methods require high energy and hazardous reagents, prompting a shift toward sustainable green biosynthesis2. Biological synthesis of NPs involves the synergy between plant extracts and microorganisms such as fungi, bacteria, and microalgae, as eco-friendly stabilizers and reducing agents3–5. The synergy created when these biogenic NPs are combined with natural polymers (e.g., chitosan) or traditional antibiotics enhances biocompatibility and exerts potential antimicrobial activities against multidrug-resistant (MDR) pathogens, and helps restore the potency of co-administered drugs. This integrated strategy represents a vital frontier in nanotechnology, transforming weak conventional treatments into powerful, sustainable tools capable of overcoming the global challenge of MDR6–8. Actinobacteria, particularly the genus Streptomyces, are prized for their metabolic diversity and ability to secrete proteins and enzymes that facilitate nanoparticle formation9,10. While soil-dwelling actinobacteria are well-studied, endophytic strains—which inhabit plant tissues and possess unique metabolic profiles—remain an underexploited resource for discovering novel biosynthetic pathways11–13. Zinc is an essential trace element, and ZnO is classified as Generally Recognized As Safe (GRAS) by the FDA. In microbial synthesis, extracellular biomolecules, including putative NADH-dependent reductases, likely function as nucleation-directing and capping agents, controlling particle morphology and stability14. The pathway from nucleation to calcination is summarized in Fig. 1. ZnO NPs also exhibit potent antimicrobial activity through the generation of reactive oxygen species (ROS) and direct membrane disruption15. Despite this, the potential of Streptomyces werraensis isolated from medicinal plants like Passiflora caerulea remains unexplored16. Given that P. caerulea is rich in bioactive phytochemicals, it may enhance the biosynthetic capacity of its associated endophytes. To the best of our knowledge, no prior study has reported the biosynthesis of ZnONP using an endophytic S. werraensis strain derived from P. caerulea. In this study, we biosynthesized and characterized ZnO NPs using the cell-free supernatant of this strain. We analyzed the structural and morphological properties via UV–Vis, FTIR, DLS, TEM, and SAED. We evaluated the antibacterial efficacy of the particles against pathogenic bacteria to assess their potential for biomedical applications. Materials and methods Isolation and characterization of endophytic actinomycetes from P. caerulea Plant samples of P. caerulea L. were collected from the Botanical Garden at The Maharaja Sayajirao University (MSU) of Baroda, Vadodara, India (22.3072°N, 73.1812°E) in October 2024. Dr. P. Nagar performed plant authentication at the Department of Botany, MSU, Vadodara, India. The plant’s fresh, healthy roots, leaves, and stems were utilized for isolation. The samples were washed with sterile distilled water to remove soil particles. Surface sterilization was performed by immersing them in 70% ethanol for 30 s, followed by treatment with 3–5% sodium hypochlorite (available chlorine) for 3 min. The samples were thoroughly rinsed with sterile water to remove all epiphytic microorganisms. To confirm the efficiency of surface sterilization, the final rinse water was plated on nutrient agar (NA) and Actinomycete Isolation Agar (AIA) plates and incubated for 5 days at 28 °C. The absence of microbial growth confirmed the sterility of the process and ensured that the isolated endophytes were truly endophytic. Subsequently, the roots were dissected into 1-cm pieces and aseptically transferred to AIA17,10. The isolate was morphologically identified using Gram staining16. Molecular identification of the actinomycete strain was performed by amplifying the 16S rRNA gene with universal primers. The protocol included DNA isolation, PCR amplification, and sequencing of the 16S rRNA gene (Supplementary Fig. S1, Gel blot). To accomplish this, forward primers 27F (5’-AGAGTTTGATCMTGGCTCAG-3’) and 518 F (5’-CCAGCAGCCGCGGTAATACG-3’), as well as reverse primers 1492R (5’-TACGGYTACCTTGTTACGACTT-3’) and 800R (5’-TACCAGGGTATCTAATCC-3’), were employed. The evolutionary history was inferred using the Neighbor-joining method. The bootstrap consensus tree, inferred from 1000 replicates, was used to represent the evolutionary history of the taxa analyzed (17, 12). Branches corresponding to partitions that were reproduced in fewer than 50% of bootstrap replicates were collapsed. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is shown next to the branches8. The evolutionary distances were computed using the Jukes-Cantor method18 and are expressed in units of base substitutions per site. This analysis involved 11 nucleotide sequences. All ambiguous positions were removed for each sequence pair (via the pairwise deletion option). There was a total of 1269 positions in the final dataset. Evolutionary analyses were conducted in MEGA1119. Microbial synthesis of ZnO NPs Preparation of cell-free supernatant The cell-free supernatant approach was selected to utilize extracellular metabolites (proteins, enzymes, and organic acids) secreted during bacterial growth. Extracellular biosynthesis offers several advantages: (1) simplified downstream processing without the need for cell lysis, (2) reduced contamination from intracellular debris, (3) more effortless scalability for industrial applications, and (4) utilization of naturally secreted reducing enzymes such as NADH-dependent reductases. Previous studies have demonstrated that extracellular proteins and enzymes from actinobacteria are sufficient for the practical synthesis of metal oxide nanoparticles. The well-cultured actinomycete was inoculated into 100 mL of sterile Luria broth (LB) and incubated at 28 °C for 4–5 days with continuous shaking at 220 rpm until the optical density (OD600) reached 1.2. Following incubation, the cell-free supernatant was obtained by centrifuging the culture broth at 11,952 × g for 15 min at 4 °C. The total protein concentration of the CFS was estimated using the Bradford assay and served as a proxy for the metabolite load prior to nanoparticle synthesis. The resulting CFS was subsequently used to synthesize ZnO NPs16. Synthesis of ZnO NPs ZnO NPs were synthesized following the method of Balraj et al.20. For synthesis, 100 mL of cell-free supernatant obtained from 5-day-cultured S. werraensis was monitored for reaction progress; the color change from dark green to milky white indicated ZnO NP formation. Note that malachite green does not participate in the reduction reaction but serves solely as an optical indicator. Although zinc chloride and NaOH were used to supply precursor ions and adjust pH, the biological metabolites secreted by S. werraensis. The biological metabolites secreted by S. werraensis are proposed to act as nucleation templates and capping agents during Zn(OH)2 precipitation, with final ZnO formation occurring upon thermal dehydration and calcination at 400 °C. Therefore, the process represents a biologically assisted green synthesis in which microbial metabolites govern nucleation and surface stabilization, rather than acting as classical chemical reductants. Subsequently, all flasks were incubated at 30 °C for 72 h with continuous agitation at 220 rpm. A noticeable change occurred, shifting from dark green to milky white, signifying the formation of ZnO NPs. The dry particles were then collected following centrifugation at 11,952 × g for 15 min. This washing procedure with sterile distilled water was repeated three times. After washing, the NPs were initially dried at 80 °C for 72 h to remove moisture, followed by calcination at 400 °C for 2 h in a muffle furnace to ensure complete conversion to crystalline ZnO and removal of organic residues21,22. Physico-chemical analysis of ZnO NPs UV– visible spectroscopy analysis Absorption spectroscopy is a potent, non-destructive method that leverages the optical properties of semiconducting nanoparticles. It is beneficial for determining the relationship between UV-Vis absorption spectra and the nanoparticles’ size and corresponding wavelength. The energy difference between the valence and conduction bands establishes the bandgap energy (Eg). For semiconducting metal oxides such as ZnO, the characteristic absorption in the 300–380 nm region arises from exciton absorption at the band-gap transition (Eg ≈ 3.37 eV for bulk ZnO), not from surface plasmon resonance (SPR), which is a phenomenon restricted to metallic nanoparticles (Au, Ag, and Cu). A Tauc plot analysis was performed on the UV-Vis spectral data to estimate the optical band-gap energy (Eg) of the biosynthesized ZnO NPs. A redshift in the absorption onset corresponds to an increase in the effective nanoparticle size and a decrease in the band-gap energy23. UV-Vis spectrometric measurements were conducted using a double-beam spectrophotometer over the 200–800 nm range. The sample with the highest intensity was selected for further characterization. Fourier transform infrared (FTIR) analysis Fourier-transform infrared spectroscopy (FTIR) was employed to ascertain the presence of various functional groups associated with synthesizing zinc oxide nanoparticles. The zinc oxide nanoparticles were dried and transformed into a powder for FTIR analysis. This powder was mixed with potassium bromide (KBr) at a 2:98 weight ratio and subsequently pressed at 11,000 psi to form a disc. The detector was carefully purged with clean, dry nitrogen gas to ensure optimal signal quality and minimize moisture interference. Following this, the discs were placed in the spectrophotometer, and the spectrum was recorded over a scan range of 4000–400 cm− 1. The FTIR spectra were further examined and analyzed using an online spectroscopic analysis tool24. Dynamic Light Scattering (DLS) analysis The particle size was assessed using dynamic light scattering (DLS), an instrumental technique that measures the hydrodynamic diameter, including effects of the biomolecular corona and aggregation. This method accommodates sample suspension concentrations ranging from 0.00001% to 40% and is sensitive enough to resolve molecular weights as low as 250 Da. Dynamic light scattering is a commonly used method for measuring particle size in colloidal solutions. Using this technique, the average particle size, particle size distribution, and polydispersity index (PDI) of the synthesized Zn oxide nanoparticles were determined25. Transmission Electron Microscope (TEM) analysis Transmission electron microscopy (TEM) images provide valuable insights into the morphology and size of ZnO NPs. All samples were prepared for TEM analysis by drop-coating nanoparticle solutions onto carbon-coated copper grids at room temperature. Any excess nanoparticle solution was carefully eliminated using filter paper. Subsequently, the copper grids were air-dried at room temperature before TEM analysis. The analysis was conducted using the JEM-1400 PLUS model instrument, operating at an accelerating voltage of 200 kV. Individual particle diameters were measured from TEM images using ImageJ software (n = 100 particles) to determine average particle size and size distribution26,27. Selected area electron diffraction (SAED) Selected-area electron diffraction analysis was used to investigate the crystalline nature of the nanoparticles. This technique played a key role in characterizing the morphology and structural properties of the NPs. Antimicrobial activity The antibacterial potential of the biosynthesized ZnO NPs was evaluated against five clinically relevant bacterial strains: S. aureus, B. subtilis, E. coli, S. paratyphi A, and P. vulgaris. Each bacterial culture (0.1 mL) was inoculated onto nutrient agar plates, and wells were loaded with varying concentrations of ZnO NPs (50, 100, 150, and 200 µL). Critical controls included: Ampicillin (150 µg/mL) as the positive control; heat-inactivated supernatant; and distilled water (no Zn2+ ions) as the negative control (to distinguish ionic vs. nanoparticle effects). The plates were incubated at 30 °C for 24 h, and the diameter of the zone of growth inhibition was recorded in millimeters24. DPPH radical scavenging assay The DPPH free radical scavenging assay was performed following the method of Figueiredo et al. Different concentrations of ZnO NPs (50, 100, 150, and 200 µL) were prepared in distilled water. Each sample (1 mL) was mixed with 2 mL of freshly prepared DPPH solution and incubated in the dark at 28 °C for 20 min. The negative control consisted of 1 mL DPPH solution and 2 mL distilled water. Absorbance was read at 517 nm28. Radical scavenging activity (%) was calculated as: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\mathrm{Scavenging~activity~}}\left( {{\% }} \right)=\frac{{Cabs - Sabs}}{{{\mathrm{Cabs}}}} \times 100$$\end{document} Where, Cabs= Absorbance of control, Sabs = Absorbance of sample. ABTS radical scavenging assay The ABTS·+ scavenging assay was performed as described by Baran et al.29. ABTS·+ was generated by reacting ABTS (7 mM) with 2.45 mM potassium persulfate and incubating the mixture in the dark for 12–16 h. The working solution was diluted with distilled water to obtain an absorbance of 0.700 ± 0.002 at 734 nm30. AgNP samples and standards (1 mL) were mixed with 3.9 mL of ABTS·+ solution, vortexed, and the absorbance was recorded within 6 min. Percentage inhibition was calculated using the same formula as the DPPH assay. Statistical analysis All experiments were performed in triplicate (n = 3), and results are expressed as mean ± standard deviation (SD). Statistical significance was determined by one-way analysis of variance (ANOVA) followed by Tukey’s honestly significant difference (HSD) post-hoc test, with significance thresholds set at p < 0.05. Results Isolation and molecular identification of the isolates by 16 S rRNA gene sequence analysis and phylogenetic analysis The medicinal Plant P. caerulea L. (Passifloraceae) was used to isolate actinomycetes from its stem through surface sterilization on Actinomycete Isolation Agar (AIA) (Supplementary Fig. S2a). The obtained isolate was subsequently employed for the green synthesis of zinc nanoparticles with antibacterial activity. Microscopic examination of Gram-stained actinomycete isolates was conducted. These actinomycetes exhibited a purple coloration under 100x magnification, indicating their filamentous nature as Gram-positive bacteria (Supplementary Fig. S2b). Purification of the PCR products, as shown in Fig. 2a and b, was performed to eliminate unincorporated PCR primers and dNTPs. The PCR sequences of the isolate were then compared with other sequenced streptomyces in the NCBI database, revealing similarities to sequences from various other streptomyces. A BLAST search of the 16 S rRNA gene sequence revealed 99% similarity with Streptomyces werraensis (Fig. 3). This isolate, M1 4005, was identified as Streptomyces werraensis, and its 16 S rRNA gene sequence was deposited in NCBI Gene under the accession number PX480009.1.Phylogenetic analysis using the neighbor-joining method with 1000 bootstrap replicates confirmed the isolate’s taxonomic position within the Streptomyces werraensis clade. The phylogenetic tree was constructed in MEGA X using closely related Streptomyces species retrieved from the NCBI database. To our knowledge, based on extensive literature searches (PubMed, Web of Science, Google Scholar; searched January 2025), this represents the first report of S. werraensis isolated from P. caerulea as an endophyte, though S. werraensis has previously been isolated from other environmental sources, including soil and marine environments. Preparation of cell-free supernatant An apparent color change occurred during synthesis. The solution gradually shifted from dark green to milky white, visually indicating the formation of ZnO NPs (Supplementary Figures S3a and S3b). This color change reflects the reduction of the zinc chloride precursor, likely driven by bioactive compounds in the cell-free supernatant (CFS) of the PS-1 isolate. Synthesis and characterization of ZnO NPs Following a series of washing and thermal treatment steps, dry white powdery ZnO NPs were successfully obtained (Supplementary Figure S3c). The synthesis yield was estimated as the weight of dried ZnO NPs obtained per unit of total zinc precursor used. Approximately 0.83 g of dry ZnO NPs nanoparticles were recovered from 1.0 g equivalent of zinc chloride precursor, corresponding to a conversion efficiency of ~ 83%. This high yield reflects the effective role of microbial metabolites in promoting the complete reduction and conversion of Zn²⁺ ions to ZnO, indicating good scalability for larger-batch synthesis. Optical studies for the synthesized nanomaterials The UV–visible absorption spectrum of ZnO NPs confirmed their successful formation (Fig. 4). Distinct peaks observed between 200 and 300 nm correspond to the strong absorption of peptide bonds, indicating the presence of aromatic amino acids, such as tryptophan and tyrosine, in the filtrate. These biomolecules, likely secreted proteins and secondary metabolites, may act as nucleation-directing and capping agents, stabilizing the nanoparticles by preventing agglomeration. A Tauc plot derived from the UV-Vis data yielded an estimated optical band-gap energy (Eg) of approximately 3.28 eV for the biosynthesized ZnO NPs, slightly lower than bulk ZnO (3.37 eV), consistent with quantum confinement effects reported for biogenic ZnO nanostructures. Identification of the active ingredients for the reduction of ZnO NPs FTIR analysis was used to identify the functional groups involved in the reduction and stabilization of ZnO NPs synthesized using an extract of the P. caerulea-associated actinomycete. The FTIR spectrum showed several characteristic absorption bands, confirming the formation of ZnO NPs via biomolecule-assisted synthesis (Fig. 5). The broad absorption band observed at 3396–3500 cm–1 corresponds to the hydroxyl (-OH) stretching vibration, indicating the presence of phenolic or aliphatic compounds that act as reducing and stabilizing agents. The peak at 2939 cm–1 is attributed to C–H stretching vibrations of methyl, methylene, and methoxy groups, representing aliphatic compounds originating from secondary metabolites. Absorption bands in the range of 1645–1695 cm–1 are assigned to C = O stretching of amide and carbonyl groups, while peaks observed between 1500 and 1570 cm–1 correspond to C = O and C = N stretching vibrations, suggesting the involvement of proteins and other nitrogenous compounds in nanoparticle formation. The band at 1400–1430 cm–1 can be ascribed to the aromatic C = C stretching of polyphenolic constituents. Furthermore, absorption peaks between 1060 and 1020 cm–1 correspond to C–O stretching vibrations of alcohols and esters, indicating the presence of oxygenated functional groups in the biomolecules. A distinct band between 625 and 690 cm–1, along with additional vibrations below 700 cm–1, confirms the presence of Zn–O stretching, characteristic of ZnO NPs (Table 1). These findings strongly suggest that various functional groups originating from bioactive metabolites acted as reducing and capping agents during nanoparticle synthesis, stabilizing the nanoparticles and preventing agglomeration. Similar functional group involvement has been reported in previous green synthesis studies, supporting the role of biological molecules in ZnO NPs formation and stabilization. Crystalline properties of the synthesized nanomaterials DLS analysis was performed to determine the hydrodynamic particle size and size distribution of the biosynthesized ZnO NPs. The obtained DLS spectrum (Fig. 6) showed an average hydrodynamic particle size of 548 nm with a polydispersity index (PDI) of 0.620. Importantly, DLS measures the hydrodynamic diameter in aqueous suspension—including the hydration shell and biomolecule-mediated agglomerate clusters—and thus yields substantially larger values than the primary particle size determined by TEM (~ 136 nm). This TEM-versus-DLS discrepancy is well recognized in biogenic nanoparticle systems. The relatively high PDI value indicates moderate polydispersity arising from non-uniform nucleation driven by heterogeneous metabolite populations. A TEM-based size distribution histogram (n = 100 particles, ImageJ) confirming a mean primary diameter of 136 ± 22 nm is presented in Fig. 6. Zeta potential measurement was not performed and is acknowledged as a limitation. These findings confirm that the biomolecules present in the extract not only facilitated the reduction of zinc ions but also influenced the colloidal stability and size distribution of the resulting nanoparticles. Despite observed size variation in the hydrodynamic state, DLS results remain consistent with the biological synthesis mechanism, in which biomolecular interactions govern nanoparticle growth and stabilization. Surface morphology of the fabricated nanomaterials TEM was employed to investigate the morphology and structural characteristics of the synthesized ZnO NPs. TEM micrographs (Fig. 7a and b) revealed that the nanoparticles were predominantly spherical in shape, with an average diameter of approximately 136–137 nm. Similar particle dimensions have also been reported in previous studies, where ZnO NPs synthesized via electrochemical and green routes exhibited sizes of 200–260 nm, supporting the plausibility of our observed dimensions. The images also showed loosely associated clusters, indicating that the nanoparticles existed as soft agglomerates, a typical feature of green-synthesized ZnO NPs due to interparticle interactions such as Van der Waals forces and hydrogen bonding. The clear lattice fringes observed in several particles confirm the crystalline nature of ZnO, in good agreement with previously reported morphologies of biosynthesized ZnO NPs. The uniform spherical morphology further supports the role of biomolecules in controlling nucleation and growth during nanoparticle formation, ensuring structural stability and reducing particle aggregation. The uniform spherical morphology further supports the role of biomolecules in controlling nucleation. Notably, the high surface-area-to-volume ratio of these predominantly spherical particles (approx 136 nm) is a critical determinant for their bioactivity, providing extensive surface sites for the adsorption of water and oxygen, which are essential precursors for the generation of ROS. SAED patterns revealing crystalline structure The SAED image of ZnO NPs displayed single and polycrystalline lattice planes, with the ring pattern representing agglomerated particles possessing a polycrystalline nature. The single-line dots, on the other hand, indicated individual crystallites. SAED pattern analysis also unveiled variations in the crystal lattice planes of these particles (Fig. 8). Antibacterial activity The biosynthesized ZnO NPs exhibited a concentration-dependent antibacterial activity. No growth inhibition was observed for S. aureus at lower concentrations of ZnO NPs(50 and 100 µL), but a measurable zone appeared at 150 µL (9.2 ± 0.54 mm) and increased slightly at 200 µL (11.0 ± 0.61 mm). B. subtilis showed moderate inhibition beginning at 100 µL (8.6 ± 0.47 mm), which increased to 13.0 ± 0.72 mm at 200 µL. Among Gram-negative bacteria, E. coli displayed inhibition zones (diameter) ranging from 7.8 ± 0.52 mm at 50 µL to 15.2 ± 0.70 mm at 200 µL. At the same time, S. paratyphiA exhibited the highest antibacterial activity (Fig. 9a), with inhibition zones of 10.2 ± 0.63 mm at 50 µL and 19.0 ± 0.64 mm at 200 µL. P. vulgaris also showed notable inhibition (Fig. 9b) (8.4 ± 0.48 mm at 50 µL to 16.4 ± 0.68 mm at 200 µL) (Table 2) compared to the control (Fig. 9c and d). The positive control (Ampicillin at 150 µg/mL) inhibited the growth of all microbial cultures under study. Heat-inactivated supernatant and distilled water (no Zn²⁺ ion) did not inhibit the growth of any of the microbial cultures under study. Overall, the antibacterial effect of ZnO NPs increased proportionally with concentration and was more pronounced against Gram-negative bacteria, suggesting that the thinner peptidoglycan layer and higher membrane permeability facilitate greater interaction with nanoparticles. The maximum activity observed at 200 µL was comparable to that of the positive control (Ampicillin 150 µg/mL), indicating notable antimicrobial potential of ZnO NPs. Direct potency equivalence between nanoparticles and conventional antibiotics cannot be established from well-diffusion data alone, as nanoparticle diffusion in agar is governed by size, charge, and hydration shell, rendering direct comparison with ampicillin provisional. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) determinations are prioritized for follow-up studies involving Streptomyces werraensis. The maximum activity observed at 200 µL was comparable to that of the positive control (Ampicillin 150 µg/mL). Antioxidant assay ZnO NPs demonstrated significant dose-dependent radical-scavenging activity (Fig. 10). A progressive increase in antioxidant activity was evident at increasing concentrations of ZnO NPs. In the DPPH assay, 200 µg/mL yielded the maximum IC50 value of 43.02 ± 1.2 µg/mL compared to 22.15 ± 0.8 µg/mL for Ascorbic Acid. In comparison, in the ABTS assay, ZnO NPs showed a higher potency of 22.15 ± 1.2 µg/mL, approaching the standard Ascorbic Acid (14.80 ± 20.5 µg/mL). Discussion The isolation of endophytic actinomycetes from P. caerulea L. signifies the value of medicinal plants as reservoirs for unique microbial diversity. The present study successfully isolated a Gram-positive, filamentous bacterium on AIA. Molecular identification based on 16 S rRNA gene sequencing, followed by phylogenetic analysis using the neighbor-joining method, confirmed the isolate’s taxonomic position within the S. werraensis clade. While this species is known in soil and marine environments, its identification as an endophyte within P. caerulea represents a first report. Lang et al.31 suggest that endophytic Streptomyces undergo genomic adaptations that enhance their metabolic potential compared to soil-dwelling strains. Furthermore, the choice of this isolate for green synthesis is validated by Shaban et al.32, who noted that endophytic reductases facilitate the production of highly stable, “capped” nanoparticles with superior bioactivity. The results of the present study highlight S. werraensis as a potent biological factory for producing ZnO NPs to combat MDR pathogens. The microbial synthesis of ZnO NPs presents a promising avenue for developing eco-friendly nanomaterials with significant antimicrobial potential. This study successfully demonstrated the biosynthesis of ZnO NPs using an endophytic actinomycete isolated from P. caerulea (Krishna Kamal), highlighting the efficiency of biological systems in nanomaterial synthesis. Selecting P. caerulea as the plant source offers several advantages. This medicinal plant is known to produce diverse secondary metabolites, including flavonoids, alkaloids, and glycosides, which may enhance the reducing capacity of the endophytic microorganisms. The endophytic S. werraensis isolated from this niche may harbor or produce complementary biomolecules suitable for stable nanoparticle synthesis33. Furthermore, endophytes from medicinal plants often exhibit enhanced production of antimicrobial metabolites compared to soil isolates, potentially translating into improved antibacterial properties in the synthesized nanoparticles. The plant-endophyte combination thus offers dual advantages: a sustainable source of material and potentially superior bioactive properties34. Similar findings were reported by Kadam et al.35, who observed fluorescence at 280 nm, confirming the presence of tyrosine residues in the protein capping layer of ZnO NPs. The results suggest that secondary metabolites secreted by S. werraensis participate in Zn(OH)2 nucleation and surface capping. While NaOH-driven Zn(OH)2 precipitation and thermal calcination (at 400 °C) are the dominant chemical transformation steps, biological molecules are proposed to govern nucleation template formation and post-precipitation surface stabilization rather than acting as classical reductants23. This aligns with recent insights summarized by Chan et al.36, who reviewed diverse mechanistic pathways underlying green synthesis and highlighted the crucial interplay between microbial metabolites, pH, and reaction kinetics in controlling nanoparticle morphology and stability. This study used comparative FTIR analysis to identify the active biomolecules responsible for ZnONP biosynthesis. The spectral changes between the cell-free supernatant and the synthesized nanoparticles clearly demonstrated protein interaction with ZnO. The shift and intensity reduction of amide I and amide II bands, coupled with the appearance of characteristic Zn-O peaks (625–690 cm− 1), confirmed that extracellular proteins played a crucial role in reduction, capping, and stabilization. These proteins likely formed a coating around the nanoparticles, preventing agglomeration through electrostatic interactions involving free amino, phosphate, or carboxyl groups37,38. Aliphatic compounds (observed at 2939 cm− 1) further support the organic matrix. This biological coating, supported by secretions identified by ensures particle stabilization and enhances biocompatibility for biomedical use39,40. TEM analysis revealed the formation of roughly spherical ZnO particles that appeared as agglomerates, with an average apparent size of 136–137 nm. However, these clusters are composed of much smaller primary nanoparticles in the nanometer range, which tend to aggregate due to biomolecule-mediated capping and van der Waals interactions, a phenomenon commonly observed in biologically synthesized ZnO NPs. Similar aggregation has been reported in earlier green synthesis studies41. Comparable results have been observed for other metal oxide nanoparticles synthesized from fruit husks, such as CuONPs produced using durian husk extract42,43. DLS analysis revealed an average hydrodynamic diameter of ~ 548 nm with a polydispersity index (PDI) of 0.620. The relatively high PDI suggests moderate polydispersity, influenced by differences in nucleation and growth rates within the microbial filtrate. This size is substantially larger than the TEM primary size (~ 136 nm) because DLS measures the full hydrodynamic corona—including the biomolecular “cap” and hydration layer—in suspension44. Despite this clustering, the NPs typically retain a negative zeta potential, providing electrostatic repulsion that limits sedimentation. While long-term stability testing across pH ranges was not performed here, visual observations indicated structural stability after multiple washing steps. Future work will evaluate the colloidal stability across pH values (4–10) to determine suitability for real-world applications. Our study’s findings align with previous research, exemplified by Dhanabal et al.45, who explored the enhanced visible-light photocatalytic activity of strontium-doped ZnO NPs. A strong capping layer of proteins and metabolites offers the long-term stability to biosynthesized ZnO NPs. However, bio-template degradation or fluctuations in ionic strength can trigger van der Waals-driven aggregation over time, increasing hydrodynamic diameter as measured by DLS. Despite this clustering, the NPs typically retain a negative zeta potential, providing electrostatic repulsion that limits sedimentation46,47. The results demonstrate a clear concentration-dependent inhibitory effect. As the volume of S. werraensis-derived ZnO NPs increased from 50 µL to 200 µL, a consistent expansion in the Zone of Inhibition (ZOI) was observed, likely due to a greater release of ROS48. The lack of activity in distilled water and heat-inactivated controls confirms that antimicrobial properties are intrinsic to the ZnO NPs rather than the medium49. The lack of inhibition at low concentration against Gram-positive bacteria could be attributed to the thicker peptidoglycan layer, which impedes nanoparticle penetration and reduces ROS-mediated damage50,36. A distinct preference for Gram-negative strains was evident, with S. paratyphi A exhibiting the highest ZOI (19.0 ± 0.64 mm). Gram-negative membranes, rich in lipopolysaccharides, provide a negative surface charge that facilitates the attachment of positively charged ZnO NPs. In contrast, Gram-positive S. aureus was the most resilient (modest inhibition at 200 µL), as its thick peptidoglycan layer (20–80 nm) acts as a robust physical barrier trapping nanoparticles50. The bactericidal effect likely follows a multi-step oxidative pathway: biogenic capping agents facilitate docking, and once localized, ZnO NPs act as “nanogenerators” of ROS (such as H2O2 and ·OH), inducing lipid peroxidation and DNA damage51. Furthermore, the release of Zn2+ ions interferes with respiratory enzymes, leading to cytoplasmic leakage and cell lysis. Since ZOI values were comparable to or exceeded those of Ampicillin, this ROS-mediated pathway may be less susceptible to β-lactamase-based resistance. This antimicrobial effect is hypothesized to result from increased interaction between Zn2+ ions and the bacterial outer membrane, thereby disrupting the lipid bilayer and generating ROS3–5. This growth inhibition is proposed to involve a synergistic pathway: (i) physical disruption of the lipid bilayer via nanoparticle–cell wall adhesion, and (ii) induction of oxidative stress. These mechanisms remain to be directly confirmed in the current study and are presented as proposed interpretations consistent with the broader ZnONP antibacterial literature. The Zn2+ ions released into the medium, combined with the presence of ZnO NPs on the bacterial surface, are known to trigger the photocatalytic and metabolic production of ROS, such as superoxide radicals (.O2) and hydroxyl radicals (.OH), which lead to irreversible DNA and protein damage6–8. Beyond antibacterial activity, the ZnO NPs demonstrated significant dose-dependent radical scavenging, reaching peak efficacy at 200 µg/mL. This aligns with Shaban et al.32, who noted that biogenic NPs exhibit heightened electron-transfer capabilities due to surface-area saturation. The versatility was highlighted by an IC50 of 43.02 ± 1.2 µg/mL in the DPPH assay. While lower than ascorbic acid, they are more effective than chemically synthesized ZnO NPs because biogenic “capping” phytochemicals act synergistically with the ZnO core52. In the ABTS assay, the IC50 was 22.15 ± 1.2 µg/mL, nearly matching the standard. According to Lang et al.31, ZnO NPs often show a higher affinity for the ABTS+cation because the assay applies to both hydrophilic and lipophilic systems, allowing the diverse biogenic surface coatings to exert their full reductive potential53–56. Biogenic synthesis using endophytic S. werraensis produced ZnO NPs with a primary TEM size of ~ 136 nm, larger than typically reported for other strains10, yet exhibiting superior docking and ROS generation40,57. The enhanced bioactivity supports application in wound healing and antibacterial formulations, positioning these as candidates for treating persistent Gram-negative infections58. Recent biogenic synthesis leverages plant extracts and microorganisms, and polymers to produce NPs under eco-friendly conditions6,7,59. These biogenic NPs exhibit high biocompatibility and unique synergy when combined with traditional antibiotics such as ceftazidime or fosfomycin 60. This integrated strategy enhances antimicrobial potency against MDR pathogens by simultaneously inducing oxidative stress and disrupting bacterial membranes60. Such synergistic nanocomposites effectively restore antibiotic efficacy, offering a sustainable solution to global antimicrobial resistance5,6,27. Reproducibility depends on controlling microbial growth conditions—temperature and pH—to ensure the culture consistently produces the required proteins and metabolites. While biological systems can vary, the 400 °C heat treatment acts as a “great equalizer,” locking in a consistent crystal structure. Moving to an industrial scale is practical because Streptomyces spp. excrete metabolites extracellularly, simplifying collection. Using large-scale bioreactors allows for fine-tuning aeration and ingredients for mass production26,61,62. Strengths of the present study This study offers several key advantages. First, it explored a unique host-endophyte pairing—Streptomyces werraensis isolated from P. caerulea—for the biosynthesis of ZnO NPs. This effectively broadens the biological toolkit available for sustainable nanotechnology. Using a cell-free supernatant also makes the process much easier to scale compared to intracellular methods. Furthermore, we tested antibacterial activity against five clinical strains, providing a more comprehensive assessment of efficacy than many similar reports. Finally, the study employs a rigorous characterization process and provides sufficient detail on the synthesis parameters to enable other researchers to replicate our results reliably. Limitations of the present study The present work aligns with several UN Sustainable Development Goals. By developing biogenic ZnO NPs as potential antibiotic alternatives, this research supports SDG 3 (Good Health and Well-being) in the fight against antimicrobial resistance. Using an endophytic microbe as a “bio-factory” avoids the use of harsh chemicals, adhering to the green chemistry principles of SDG 12 (Responsible Consumption and Production). We also highlight the value of plant-associated microbial biodiversity in ways that do not harm the ecosystem, supporting SDG 15 (Life on Land). Finally, the potential to scale this bio-based synthesis fits within the framework of SDG 9 (Industry, Innovation, and Infrastructure). Relevance of the present study to Sustainable Development Goals (SDGs) Despite these findings, a few gaps remain unaddressed such as (i) X-ray diffraction (XRD) analysis, which could determine crystallite size or confirm the hexagonal wurtzite phase and (ii) zeta potential measurements over time, which could have clarified the stability of the particles, (iii) MTT cytotoxicity or hemocompatibility tests, which are essential before these nanoparticles can be considered for medical use (iv) mechanism for how extracellular metabolites reduce the zinc precursors need to be explored. Future perspectives To build on this work, future studies should focus on; (1) Structural Analysis: Performing XRD to confirm the wurtzite phase and calculate crystallite size, (2) Stability: Measuring zeta potential across a pH range of 4 to 10, (3) Potency: Establishing MIC and MBC values against a wider array of pathogens, including drug-resistant strains, (4) Mechanistic Controls: Using ZnCl2 and supernatant controls to distinguish between nanoparticle toxicity and ionic effects, (5) Safety Screening: Conducting hemolysis and MTT assays to determine biocompatibility, (6) Expanded Functionality: Testing radical scavenging (DPPH/ABTS) and the ability to degrade dyes like methylene blue under UV and visible light, and (7) Metabolite Profiling: Utilizing LC-MS or proteomics to identify the specific molecules responsible for stabilizing and nucleating the ZnO NPs. Conclusion The successful isolation of endophytic S. werraensis from the medicinal plant P. caerulea L. marks a significant milestone in sustainable nanotechnology. This study is the first report of S. werraensis as an endophyte of this host, positioning it as an efficient, eco-friendly “biological factory” for synthesizing ZnO NPs. The biosynthesized ZnO NPs demonstrated potent, concentration-dependent antibacterial activity, with distinct efficacy against Gram-negative pathogens (S. paratyphi A, P. vulgaris, and E. coli). This susceptibility is driven by a multi-step “killing mechanism” involving membrane disruption and a lethal burst of ROS. Furthermore, the NPs exhibited high antioxidant potential, with ABTS radical scavenging activity nearly rivaling the standard ascorbic acid—a result of the synergistic “capping” by bioactive phytochemicals. While the study confirms the potential of these NPs for wound healing, food packaging, and antimicrobial coatings, DLS analysis suggests that further refinement is needed to optimize size uniformity and minimize aggregation. Future research should focus on elucidating the specific enzymatic pathways involved in reduction and conducting in vivo biocompatibility trials. Ultimately, this green synthesis approach underscores the potential of utilizing novel medicinal plant-endophyte combinations to produce high-performance, sustainable nanomaterials. Fig. 1The pathway illustrates the transition from metabolite-mediated nucleation to final physicochemical calcination. The pathway illustrates the transition from metabolite-mediated nucleation to final physicochemical calcination. Fig. 2Amplification of the 16 S rRNA gene from the genomic DNA of the isolate. (a) A standard DNA molecular weight marker (Ladder) is used to verify that the PCR product corresponds to the expected size for the 16 S rRNA gene. (b) The specific lane containing the purified amplicons was generated using the 27 F/1492R primer set. Amplification of the 16 S rRNA gene from the genomic DNA of the isolate. (a) A standard DNA molecular weight marker (Ladder) is used to verify that the PCR product corresponds to the expected size for the 16 S rRNA gene. (b) The specific lane containing the purified amplicons was generated using the 27 F/1492R primer set. Fig. 3Phylogenetic Tree of Isolate M1 4005. Evolutionary relationships among isolates were inferred from 16 S rRNA gene sequence alignments with representative Streptomyces species. The tree highlights the position of the query sequence, which clusters most closely with S. werraensis. Numbers at nodes represent bootstrap values from 1,000 replicates, indicating branch reliability. Branch lengths represent genetic distances, confirming that M1 4005 belongs to the genus Streptomyces. Phylogenetic Tree of Isolate M1 4005. Evolutionary relationships among isolates were inferred from 16 S rRNA gene sequence alignments with representative Streptomyces species. The tree highlights the position of the query sequence, which clusters most closely with S. werraensis. Numbers at nodes represent bootstrap values from 1,000 replicates, indicating branch reliability. Branch lengths represent genetic distances, confirming that M1 4005 belongs to the genus Streptomyces. Fig. 4UV–Vis absorbance spectrum of ZnO NPs confirms the formation of ZnO NPs via SPR. The green line displays a sharp absorption peak in the UV region (320–380 nm), a characteristic signature of wurtzite-phase ZnO NPs. The blue line (control) shows no significant absorbance, verifying that the nanoparticle synthesis is a result of the interaction between the S. werraensis supernatant and the zinc precursor. UV–Vis absorbance spectrum of ZnO NPs confirms the formation of ZnO NPs via SPR. The green line displays a sharp absorption peak in the UV region (320–380 nm), a characteristic signature of wurtzite-phase ZnO NPs. The blue line (control) shows no significant absorbance, verifying that the nanoparticle synthesis is a result of the interaction between the S. werraensis supernatant and the zinc precursor. Fig. 5FTIR spectrum of biosynthesized ZnO NPs. The spectrum identifies functional groups involved in the reduction and stabilization of nanoparticles. Key peaks correspond to O–H stretching (phenolics) and C = O/N–H groups (proteins), which act as capping agents. A distinct peak below 500 cm–1 confirms the successful formation of the Zn–O metal bond. FTIR spectrum of biosynthesized ZnO NPs. The spectrum identifies functional groups involved in the reduction and stabilization of nanoparticles. Key peaks correspond to O–H stretching (phenolics) and C = O/N–H groups (proteins), which act as capping agents. A distinct peak below 500 cm–1 confirms the successful formation of the Zn–O metal bond. Fig. 6Dynamic Light Scattering (DLS) analysis of ZnO NPs illustrating the hydrodynamic size distribution of the biosynthesized NPs. The peak represents the average particle diameter, while the Polydispersity Index (PDI) indicates the degree of size uniformity. Dynamic Light Scattering (DLS) analysis of ZnO NPs illustrating the hydrodynamic size distribution of the biosynthesized NPs. The peak represents the average particle diameter, while the Polydispersity Index (PDI) indicates the degree of size uniformity. Fig. 7TEM analysis of ZnO NPs. (a) Size distribution showing the average diameter of the NPs. (b) Morphological characterization reveals the specific shape and surface features of NPs. TEM analysis of ZnO NPs. (a) Size distribution showing the average diameter of the NPs. (b) Morphological characterization reveals the specific shape and surface features of NPs. Fig. 8The SAED pattern of ZnO NPs displays bright, concentric rings, confirming the polycrystalline nature of the NPs. The diffraction spots correspond to specific lattice planes of the wurtzite crystal structure, validating high crystallinity in the biosynthesized ZnO NPs. The SAED pattern of ZnO NPs displays bright, concentric rings, confirming the polycrystalline nature of the NPs. The diffraction spots correspond to specific lattice planes of the wurtzite crystal structure, validating high crystallinity in the biosynthesized ZnO NPs. Fig. 9Representative images of antimicrobial activities of ZnO NPs. 8a, 8b - negative controls showing uninterrupted bacterial growth. 8c, 8d Zones of growth inhibition against S. paratyphi A and Proteus vulgaris, respectively. The clear areas surrounding the wells demonstrate the potent, concentration-dependent bactericidal efficacy of the biosynthesized ZnO NPs. Representative images of antimicrobial activities of ZnO NPs. 8a, 8b - negative controls showing uninterrupted bacterial growth. 8c, 8d Zones of growth inhibition against S. paratyphi A and Proteus vulgaris, respectively. The clear areas surrounding the wells demonstrate the potent, concentration-dependent bactericidal efficacy of the biosynthesized ZnO NPs. Fig. 10Comparative antioxidant activity of biosynthesized ZnO NPs and Ascorbic Acid measured via DPPH and ABTS assays. Values are expressed as mean ± SD of triplicates. Different letters indicate significant differences (p < 0.05) within each concentration group according to Tukey’s HSD test. Comparative antioxidant activity of biosynthesized ZnO NPs and Ascorbic Acid measured via DPPH and ABTS assays. Values are expressed as mean ± SD of triplicates. Different letters indicate significant differences (p < 0.05) within each concentration group according to Tukey’s HSD test. Table 1FTIR peak assignments and associated biomolecules.Wavenumber (cm−1)Functional group assignmentLikely biomolecules involved3396–3500Hydroxyl (-OH) stretchingPhenolic compounds, Alcohols2939C–H stretching (methyl, methylene)Aliphatic secondary metabolites1645–1695C=O stretching (Amide I)Proteins, Carbonyl compounds1500–1570C=O and C=N stretchingProteins, Nitrogenous compounds1400–1430Aromatic C=C stretchingPolyphenols, Flavonoids1020–1060C–O stretchingAlcohols, Esters625–690Zn–O stretchingZnONPs Table 1FTIR peak assignments and associated biomolecules.Wavenumber (cm−1)Functional group assignmentLikely biomolecules involved3396–3500Hydroxyl (-OH) stretchingPhenolic compounds, Alcohols2939C–H stretching (methyl, methylene)Aliphatic secondary metabolites1645–1695C=O stretching (Amide I)Proteins, Carbonyl compounds1500–1570C=O and C=N stretchingProteins, Nitrogenous compounds1400–1430Aromatic C=C stretchingPolyphenols, Flavonoids1020–1060C–O stretchingAlcohols, Esters625–690Zn–O stretchingZnONPs FTIR peak assignments and associated biomolecules. Table 2Comparative account of antimicrobial activity of ZnO NPs and ampicillin.PathogensZone of inhibition (mm)ZnONPs (µL)Ampicillin(150 µg/mL)50100150200 S. aureus 0.00 ± 0.00d0.00 ± 0.00d9.2 ± 0.54c11.0 ± 0.61b17.0 ± 0.82a B. subtilis 0.00 ± 0.00e8.6 ± 0.47d11.4 ± 0.68c13.0 ± 0.72b18.2 ± 0.75a E. coli 7.8 ± 0.52e10.4 ± 0.61d13.6 ± 0.77c15.2 ± 0.70b17.5 ± 0.69a S. paratyphi A 10.2 ± 0.63d14.6 ± 0.72c17.2 ± 0.60b19.0 ± 0.64a18.0 ± 0.64ab P. vulgaris 8.4 ± 0.48e12.8 ± 0.66d14.8 ± 0.70c16.4 ± 0.68b18.0 ± 0.71aValues are mean (n = 3) ± standard deviations.Means within the same row followed by different letters are significantly different at p < 0.05 (Tukey’s test). Table 2Comparative account of antimicrobial activity of ZnO NPs and ampicillin.PathogensZone of inhibition (mm)ZnONPs (µL)Ampicillin(150 µg/mL)50100150200 S. aureus 0.00 ± 0.00d0.00 ± 0.00d9.2 ± 0.54c11.0 ± 0.61b17.0 ± 0.82a B. subtilis 0.00 ± 0.00e8.6 ± 0.47d11.4 ± 0.68c13.0 ± 0.72b18.2 ± 0.75a E. coli 7.8 ± 0.52e10.4 ± 0.61d13.6 ± 0.77c15.2 ± 0.70b17.5 ± 0.69a S. paratyphi A 10.2 ± 0.63d14.6 ± 0.72c17.2 ± 0.60b19.0 ± 0.64a18.0 ± 0.64ab P. vulgaris 8.4 ± 0.48e12.8 ± 0.66d14.8 ± 0.70c16.4 ± 0.68b18.0 ± 0.71aValues are mean (n = 3) ± standard deviations.Means within the same row followed by different letters are significantly different at p < 0.05 (Tukey’s test). Comparative account of antimicrobial activity of ZnO NPs and ampicillin. Values are mean (n = 3) ± standard deviations. Means within the same row followed by different letters are significantly different at p < 0.05 (Tukey’s test). Furthermore, the biosynthesis of ZnO NPs by S. werraensis holds significant potential for combating AMR. By employing an oxidative, ROS-driven bactericidal pathway, ZnO NPs bypass common β-lactamase-based resistance mechanisms, offering a sustainable alternative to traditional antibiotics. This approach replaces hazardous chemical reductants with a biogenic endophyte, effectively reducing toxic byproduct runoff and energy consumption. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1 Supplementary Material 2 Supplementary Material 2